Idiopathic bilateral facial palsy: is a causative role of anti-GM1 ganglioside and herpes simplex type 1 possible?

This is a preview of subscription content, log in to check access.

Fig. 1
Fig. 2


  1. 1.

    Jain V, Deshmukh A, Gollomp S (2006) Bilateral facial paralysis: case presentation and discussion of differential diagnosis. J Gen Intern Med 21:C7–C10

    PubMed  Article  Google Scholar 

  2. 2.

    Kennedy PG (2010) Herpes simplex virus type 1 and Bell’s palsy-a current assessment of the controversy. J Neurovirol 16:1–5

    PubMed  Article  CAS  Google Scholar 

  3. 3.

    Lockhart P, Daly F, Pitkethly M, Comerford N, Sullivan F (2009) Antiviral treatment for Bell’s palsy (idiopathic facial paralysis). Cochrane Database Syst Rev (4):CD001869

  4. 4.

    Kowal L, Gajus MA, Kornberg AJ (2004) Anti-GM1 antibodies: the cause of otherwise unexplained ophthalmoplegias? Clin Exp Opthalmol 32:411–414

    Article  Google Scholar 

  5. 5.

    Lehmann HC, Hartung HP (2009) Variants of Guillain–Barré syndrome: low incidence but high impact. J Neurol 256:1909–1910

    PubMed  Article  Google Scholar 

  6. 6.

    Susuki K, Koga M, Hirata K, Isogai E, Yuki N (2009) A Guillain–Barré syndrome variant with prominent facial diplegia. J Neurol 256:1899–1905

    PubMed  Article  Google Scholar 

  7. 7.

    Linder T, Bossart W, Bodmer D (2005) Bell’s palsy and herpes simplex virus: fact or mistery? Otol Neurotol 26:109–113

    PubMed  Article  Google Scholar 

  8. 8.

    Abiko Y, Ikeda M, Hondo R (2002) Secretion and dynamics of herpes simplex virus in tears and saliva of patients with Bell’s palsy. Otol Neurotol 23:779–783

    PubMed  Article  Google Scholar 

  9. 9.

    Murakami S, Mizobuchi M, Nakashiro Y, Doi T, Hato N, Yanagihara N (1996) Bell’s palsy and herpes simplex virus: identification of viral DNA in endonurial fluid and muscle. Ann Intern Med 124:27–30

    PubMed  CAS  Google Scholar 

  10. 10.

    Burgess RC, Michaels L, Bale JF Jr, Smith RJ (1994) Polymerase chain reaction amplification of herpes simplex viral DNA from the geniculate ganglion of a patient with Bell’s palsy. Ann Otol Rhinol Laryngol 103:775–779

    PubMed  CAS  Google Scholar 

  11. 11.

    Kanerva M, Mannonen L, Piiparinen H, Peltomaa M, Vaheri A, Pitkäranta A (2007) Search for herpes viruses in cerebrospinal fluid of facial palsy patients by PCR. Acta Otolaryngol 127:775–779

    PubMed  Article  CAS  Google Scholar 

  12. 12.

    Ang CW, Jacobs BC, Brandenburg AH, Laman JD, van der Meché FG, Osterhaus AD, van Doorn PA (2000) Cross-reactive antibodies against GM2 and CMV-infected fibroblasts in Guillain–Barré syndrome. Neurology 54:1453–1458

    PubMed  Article  CAS  Google Scholar 

  13. 13.

    Bernsen HJ, Van Loon AM, Poels RF, Verhagen WI, Frenken CW (1989) Herpes simplex virus specific antibody determined by immunoblotting in cerebrospinal fluid of a patient with the Guillain–Barré syndrome. J Neurol Neurosurg Psychiatry 52:788–791

    PubMed  Article  CAS  Google Scholar 

  14. 14.

    Santos García D, Llaneza M, Macias M, de la Fuente-Fernández R (2009) Multiple cranial neuropathy associated with herpes simplex virus infection and anti-GM2 immunoglobulin M antibodies. J Clin Neuromuscul Dis 10:199–201

    PubMed  Article  Google Scholar 

Download references

Author information



Corresponding author

Correspondence to Elena Pretegiani.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Pretegiani, E., Rosini, F., Donati, D. et al. Idiopathic bilateral facial palsy: is a causative role of anti-GM1 ganglioside and herpes simplex type 1 possible?. Neurol Sci 33, 951–953 (2012).

Download citation


  • Facial Nerve Palsy
  • IVIg Therapy
  • Miller Fisher Syndrome
  • Bilateral Facial Nerve Palsy
  • Idiopathic Facial Nerve Palsy